1. Si J, Yu C, Guo Y, Bian Z, Meng R, Yang L, et al (2019) Chronic hepatitis B virus infection and total and cause-specific mortality: A prospective cohort study of 0.5 million people. BMJ 9(4): e027696.
2. Asgari S, Chaturvedi N, Scepanovic P, Hammer C, Semmo N, Giostra E, et al (2019) Human genomics of acute liver failure due to hepatitis B virus infection: An exome sequencing study in liver transplant recipients. Viral Hepat 26(2):271-277.
3. Jefferies M, Rauff B, Rashid,H, Lam ., Rafiq S (2018) Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin. Cases 6(13):589-599.
4. Khaled IAEA, Mahmoud OM, Saleh AF, Bioumie EE (2011) Prevalence of HBV genotypes among Egyptian hepatitis patients. Mol Biol Rep 38(7):4353-4357.
5. Kashi K, Henderson L, Bonetti,A, Carninci P (2016) Discovery and functional analysis of lncRNAs: Methodologies to investigate an uncharacterized transcriptome. Biochim Biophys Acta Gene Regul Mech 1859(1):3-15.
6. Kaikkonen MU, Lam MTY, Glass CK (2011) Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 90(3):430-440.
7. Bonetti A, Carninci P (2017). From bench to bedside: The long journey of long non-coding RNAs. Curr Opin Syst Biol 3: 119–124.
8. Fiannaca A, La Rosa M, La Paglia L, Rizzo R, Urso A (2017) NRC: Non-coding RNA Classifier based on structural features. BioData Min. 10: 1–18.
9. Diamantopoulos MA, Tsiakanikas P, Scorilas A (2018) Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer. Ann Transl Med 6 (12): 241–241.
10. Ling H, Fabbri M, Calin GA (2013) MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 12 (11):847–865.
11. Yamamura S, Sumida MI, Tanaka Y (2018) Interaction and cross-talk between non-coding RNAs. Cell Mol Life Sci 75(3):467-484.
12. Gao L, Yang X, Zhang H, Yu M, Long J, Yang T (2018) Inhibition of miR-10a-5p suppresses cholangiocarcinoma cell growth through downregulation of akt pathway. Onco Targets Ther 11: 6981–6994.
13. Ye D, Zhang T, Lou G, Liu Y (2018) Role of miR-223 in the pathophysiology of liver diseases. Exp Mol Med 50(9):1-12.
14. Sagnelli E, Potenza N, Onorato L, Sagnelli C, Coppola N, Russo A (2018) Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma. World Hepatol 10 (9):558–570.
15.Guo H, Liu H, Mitchelson K, Rao H, Luo M, Xie L, et al (2011) MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology 2:54(3):808-819.
16. Kitab B, Alj HS., Ezzikouri S, Benjelloun S (2015) MicroRNAs as Important Players in Host-hepatitis B Virus Interactions. J Clin Transl Hepatol 3 (2):149–161.
17. Fernandes JCR, Acuña SM, Aok, JI, Floeter-Winter LM, Muxel SM (2019) Long non-coding RNAs in the regulation of gene expression: Physiology and disease. Non-coding RNA 17:5(1):17.
18. Leti F, DiStefano JK (2017) Long noncoding RNAs as diagnostic and therapeutic targets in type 2 diabetes and related complications. Genes (Basel) 8(8):207
19. Siddiqui H, Al-Ghafari A, Choudhry H, Al Doghaither H (2019) Roles of long non-coding RNAs in colorectal cancer tumorigenesis: A review. Mol Clin Oncol 11(2): 167–172.
20. López-Urrutia E, Bustamante Montes LP, Ladrón de Guevara Cervantes D, Pérez-Plasencia C, Campos-Parra A D (2019) Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer. Front Oncol 9:669
21. Fan CN, Ma L, Liu N (2018) Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. J Transl Med 16: 1–12.
22. Wang S, Ge W, Luo Z, Guo Y, Jiao B, Qu L, Zhang Z, Wang X (2017) Integrated analysis of coding genes and non-coding RNAs during hair follicle cycle of cashmere goat (Capra hircus). BMC Genomics 18 (1):767.
23. Dai X, Kaushi, AC, Zhang J (2019) The emerging role of major regulatory RNAs in cancer control. Front Oncol 9: 1–14.
24. Zhao Y, Guo Q, Chen J, Hu,J, Wang S, Sun, Y (2014) Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: A clinical and in vitro investigation. Oncol Rep 31(1):358–364.
25. Cao SQ, Zheng H, Sun BC, Wang ZL, Liu T, Guo .H, Shen ZY (2019) Long non-coding rna highly up-regulated in liver cancer promotes exosome secretion. World J Gastroenterol 25 (35): 5283–5299.
26. Yang C, Wu D, Gao L, Liu X, Jin Y, Wang D, Wang T, Li X (2016) Competing endogenous RNA networks in human cancer: Hypothesis, validation, and perspectives. Oncotarget 7(12): 13479–13490.
27. Motawi TK, Mady AE, Shaheen S, Elshenawy SZ, Talaat RM, Rizk SM (2019) Genetic variation in microRNA-100 (miR-100) rs1834306 T/C associated with Hepatitis B virus (HBV) infection: Correlation with expression level. Infect Genet Evol [Internet] 73:444–9.
28. Zhang Z, Wang C, Liu Z, Zou G, Li J, Lu M (2019) Host genetic determinants of hepatitis B virus infection. Front Genet 10: 1–24.
29. Kwak MS, Lee DH, Cho Y, Cho EJ, Lee JH, Yu SJ, et al (2012) Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients. PLoS One. 7(7): e41983.
30. Matsuura K, Isogawa M, and Tanaka Y (2016). Host genetic variants influencing the clinical course of Hepatitis B virus infection. J Med.Virol 88(3): 371–379.
31. Sarkar N, Chakravarty R (2015) Hepatitis B virus infection, MicroRNAs and liver disease. Int J Mol Sci 16(8): 17746–17762.
32. Han Y, Pu R, Han X, Zhao J, Zhang Y, Zhang Q, et al (2013) Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS One 8(3): e58564.
33. Al-Qahtani AA, Al-Anazi MR, Nazir N, Wani K, Abdo AA, Sanai FM, et al (2017) Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications: a study in a Saudi Arabian population. J Viral Hepat 24(12):1132–1142.
34. Fortes P, Morris K V (2016) Long noncoding RNAs in viral infections. Virus Res [Internet]. 212:1–11. 35. Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T (2018) Emerging roles of long non-coding RNA in cancer. Cancer Sci 109(7):2093–2100.
36. Hong JH, Jin EH, Chang IA, Kang H, Lee S Il, Sung JK (2020) Association between lncRNA HULC rs7763881 polymorphism and gastric cancer risk. Pharmgenomics Pers Med 13:121–126.
37. Yang X, Xie X, Xiao YF, et al (2015) The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma. Cancer Lett 360(2):119–124.
38. Zhu Y, Zhang X, Qi L, et al (2016) HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas. Oncotarget 7(12):14429–14440.
39. Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J, Zhang Y, Chen J, Shen H, Hu Z (2012) A Genetic Variant in Long Non-Coding RNA HULC Contributes to Risk of HBV-Related Hepatocellular Carcinoma in a Chinese Population 7(4): 5–8.
40. Motawi TMK, El-Maraghy SA, Sabry D, Mehana NA (2019) The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients. J Cell Biochem 120(9):14645–14656.